These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 29045045)

  • 1. Mesenchymal Stromal Cell Therapy in Bronchopulmonary Dysplasia: Systematic Review and Meta-Analysis of Preclinical Studies.
    Augustine S; Avey MT; Harrison B; Locke T; Ghannad M; Moher D; Thébaud B
    Stem Cells Transl Med; 2017 Dec; 6(12):2079-2093. PubMed ID: 29045045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Gender on Mesenchymal Stem Cell (MSC) Efficacy in Neonatal Hyperoxia-Induced Lung Injury.
    Sammour I; Somashekar S; Huang J; Batlahally S; Breton M; Valasaki K; Khan A; Wu S; Young KC
    PLoS One; 2016; 11(10):e0164269. PubMed ID: 27711256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal Stromal Cell Exosomes Ameliorate Experimental Bronchopulmonary Dysplasia and Restore Lung Function through Macrophage Immunomodulation.
    Willis GR; Fernandez-Gonzalez A; Anastas J; Vitali SH; Liu X; Ericsson M; Kwong A; Mitsialis SA; Kourembanas S
    Am J Respir Crit Care Med; 2018 Jan; 197(1):104-116. PubMed ID: 28853608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Effects of Bone Marrow-derived Versus Umbilical Cord Tissue Mesenchymal Stem Cells in an Experimental Model of Bronchopulmonary Dysplasia.
    Benny M; Courchia B; Shrager S; Sharma M; Chen P; Duara J; Valasaki K; Bellio MA; Damianos A; Huang J; Zambrano R; Schmidt A; Wu S; Velazquez OC; Hare JM; Khan A; Young KC
    Stem Cells Transl Med; 2022 Mar; 11(2):189-199. PubMed ID: 35298658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stromal derived factor-1 mediates the lung regenerative effects of mesenchymal stem cells in a rodent model of bronchopulmonary dysplasia.
    Reiter J; Drummond S; Sammour I; Huang J; Florea V; Dornas P; Hare JM; Rodrigues CO; Young KC
    Respir Res; 2017 Jul; 18(1):137. PubMed ID: 28701189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem/stromal cells stably transduced with an inhibitor of CC chemokine ligand 2 ameliorate bronchopulmonary dysplasia and pulmonary hypertension.
    Suzuki T; Sato Y; Yamamoto H; Kato T; Kitase Y; Ueda K; Mimatsu H; Sugiyama Y; Onoda A; Saito S; Takahashi Y; Nakayama T; Hayakawa M
    Cytotherapy; 2020 Apr; 22(4):180-192. PubMed ID: 32139242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchioalveolar stem cells increase after mesenchymal stromal cell treatment in a mouse model of bronchopulmonary dysplasia.
    Tropea KA; Leder E; Aslam M; Lau AN; Raiser DM; Lee JH; Balasubramaniam V; Fredenburgh LE; Alex Mitsialis S; Kourembanas S; Kim CF
    Am J Physiol Lung Cell Mol Physiol; 2012 May; 302(9):L829-37. PubMed ID: 22328358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Umbilical Cord Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Alleviate Lung Injury in Rat Model of Bronchopulmonary Dysplasia by Affecting Cell Survival and Angiogenesis.
    You J; Zhou O; Liu J; Zou W; Zhang L; Tian D; Dai J; Luo Z; Liu E; Fu Z; Zou L
    Stem Cells Dev; 2020 Dec; 29(23):1520-1532. PubMed ID: 33040709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early gestational mesenchymal stem cell secretome attenuates experimental bronchopulmonary dysplasia in part via exosome-associated factor TSG-6.
    Chaubey S; Thueson S; Ponnalagu D; Alam MA; Gheorghe CP; Aghai Z; Singh H; Bhandari V
    Stem Cell Res Ther; 2018 Jun; 9(1):173. PubMed ID: 29941022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stromal cell extracellular vesicles as therapy for acute and chronic respiratory diseases: A meta-analysis.
    Tieu A; Hu K; Gnyra C; Montroy J; Fergusson DA; Allan DS; Stewart DJ; Thébaud B; Lalu MM
    J Extracell Vesicles; 2021 Oct; 10(12):e12141. PubMed ID: 34596349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic human umbilical cord-derived mesenchymal stem cells for severe bronchopulmonary dysplasia in children: study protocol for a randomized controlled trial (MSC-BPD trial).
    Wu X; Xia Y; Zhou O; Song Y; Zhang X; Tian D; Li Q; Shu C; Liu E; Yuan X; He L; Liu C; Li J; Liang X; Yang K; Fu Z; Zou L; Bao L; Dai J
    Trials; 2020 Jan; 21(1):125. PubMed ID: 32005282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal delivery of human umbilical cord Wharton's jelly mesenchymal stromal cells restores lung alveolarization and vascularization in experimental bronchopulmonary dysplasia.
    Moreira A; Winter C; Joy J; Winter L; Jones M; Noronha M; Porter M; Quim K; Corral A; Alayli Y; Seno T; Mustafa S; Hornsby P; Ahuja S
    Stem Cells Transl Med; 2020 Feb; 9(2):221-234. PubMed ID: 31774626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are all stem cells equal? Systematic review, evidence map, and meta-analyses of preclinical stem cell-based therapies for bronchopulmonary dysplasia.
    Augustine S; Cheng W; Avey MT; Chan ML; Lingappa SMC; Hutton B; Thébaud B
    Stem Cells Transl Med; 2020 Feb; 9(2):158-168. PubMed ID: 31746123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal Stem Cell-derived Extracellular Vesicles Prevent Experimental Bronchopulmonary Dysplasia Complicated By Pulmonary Hypertension.
    Sharma M; Bellio MA; Benny M; Kulandavelu S; Chen P; Janjindamai C; Han C; Chang L; Sterling S; Williams K; Damianos A; Batlahally S; Kelly K; Aguilar-Caballero D; Zambrano R; Chen S; Huang J; Wu S; Hare JM; Schmidt A; Khan A; Young K
    Stem Cells Transl Med; 2022 Aug; 11(8):828-840. PubMed ID: 35758326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cells for the prevention and treatment of bronchopulmonary dysplasia in preterm infants.
    Pierro M; Thébaud B; Soll R
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011932. PubMed ID: 29125893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem cells from different sources show distinct therapeutic effects in hyperoxia-induced bronchopulmonary dysplasia in rats.
    Xie Y; Chen F; Jia L; Chen R; Zhang VW; Zhong X; Wang D
    J Cell Mol Med; 2021 Sep; 25(17):8558-8566. PubMed ID: 34322990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of mesenchymal stromal cell-conditioned media on measures of lung structure and function: a systematic review and meta-analysis of preclinical studies.
    Moreira A; Naqvi R; Hall K; Emukah C; Martinez J; Moreira A; Dittmar E; Zoretic S; Evans M; Moses D; Mustafa S
    Stem Cell Res Ther; 2020 Sep; 11(1):399. PubMed ID: 32933584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term, long-term and paracrine effect of human umbilical cord-derived stem cells in lung injury prevention and repair in experimental bronchopulmonary dysplasia.
    Pierro M; Ionescu L; Montemurro T; Vadivel A; Weissmann G; Oudit G; Emery D; Bodiga S; Eaton F; Péault B; Mosca F; Lazzari L; Thébaud B
    Thorax; 2013 May; 68(5):475-84. PubMed ID: 23212278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical evaluation of cell-based strategies to prevent or treat bronchopulmonary dysplasia in animal models: a systematic review.
    Lesage F; Jimenez J; Toelen J; Deprest J
    J Matern Fetal Neonatal Med; 2018 Apr; 31(7):958-966. PubMed ID: 28277906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem-cell therapy for bronchopulmonary dysplasia.
    Collins A
    Curr Opin Pediatr; 2020 Apr; 32(2):210-215. PubMed ID: 31833951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.